1 Study Coverage
1.1 Cancer Vaccines Product Introduction
1.2 Market Segments
1.3 Key Cancer Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Vaccines Market Size Growth Rate by Type
1.4.2 Preventive Cancer Vaccines
1.4.3 Therapeutic Cancer Vaccines
1.5 Market by Application
1.5.1 Global Cancer Vaccines Market Size Growth Rate by Application
1.5.2 Cervical Cancer
1.5.3 Prostate Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Cancer Vaccines Revenue 2015-2026
2.1.2 Global Cancer Vaccines Sales 2015-2026
2.2 Global Cancer Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cancer Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cancer Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cancer Vaccines Competitor Landscape by Players
3.1 Cancer Vaccines Sales by Manufacturers
3.1.1 Cancer Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Cancer Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Cancer Vaccines Revenue by Manufacturers
3.2.1 Cancer Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Cancer Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Vaccines Revenue in 2019
3.2.5 Global Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cancer Vaccines Price by Manufacturers
3.4 Cancer Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Cancer Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Vaccines Market Size by Type (2015-2020)
4.1.1 Global Cancer Vaccines Sales by Type (2015-2020)
4.1.2 Global Cancer Vaccines Revenue by Type (2015-2020)
4.1.3 Cancer Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Vaccines Market Size by Application (2015-2020)
5.1.1 Global Cancer Vaccines Sales by Application (2015-2020)
5.1.2 Global Cancer Vaccines Revenue by Application (2015-2020)
5.1.3 Cancer Vaccines Price by Application (2015-2020)
5.2 Cancer Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cancer Vaccines by Country
6.1.1 North America Cancer Vaccines Sales by Country
6.1.2 North America Cancer Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cancer Vaccines Market Facts & Figures by Type
6.3 North America Cancer Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Cancer Vaccines by Country
7.1.1 Europe Cancer Vaccines Sales by Country
7.1.2 Europe Cancer Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Vaccines Market Facts & Figures by Type
7.3 Europe Cancer Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cancer Vaccines by Region
8.1.1 Asia Pacific Cancer Vaccines Sales by Region
8.1.2 Asia Pacific Cancer Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cancer Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Cancer Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cancer Vaccines by Country
9.1.1 Latin America Cancer Vaccines Sales by Country
9.1.2 Latin America Cancer Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cancer Vaccines Market Facts & Figures by Type
9.3 Central & South America Cancer Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cancer Vaccines by Country
10.1.1 Middle East and Africa Cancer Vaccines Sales by Country
10.1.2 Middle East and Africa Cancer Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cancer Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Cancer Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Corporation Information
11.1.2 Glaxosmithkline Description and Business Overview
11.1.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Glaxosmithkline Cancer Vaccines Products Offered
11.1.5 Glaxosmithkline Related Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Corporation Information
11.2.2 Astellas Pharma Description and Business Overview
11.2.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Pharma Cancer Vaccines Products Offered
11.2.5 Astellas Pharma Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Cancer Vaccines Products Offered
11.3.5 Merck Related Developments
11.4 CSL Limited
11.4.1 CSL Limited Corporation Information
11.4.2 CSL Limited Description and Business Overview
11.4.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CSL Limited Cancer Vaccines Products Offered
11.4.5 CSL Limited Related Developments
11.5 Sanpower Group
11.5.1 Sanpower Group Corporation Information
11.5.2 Sanpower Group Description and Business Overview
11.5.3 Sanpower Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanpower Group Cancer Vaccines Products Offered
11.5.5 Sanpower Group Related Developments
11.6 Sanofi Pasteur
11.6.1 Sanofi Pasteur Corporation Information
11.6.2 Sanofi Pasteur Description and Business Overview
11.6.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Pasteur Cancer Vaccines Products Offered
11.6.5 Sanofi Pasteur Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description and Business Overview
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Cancer Vaccines Products Offered
11.7.5 Pfizer Related Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Corporation Information
11.8.2 Serum Institute of India Description and Business Overview
11.8.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Serum Institute of India Cancer Vaccines Products Offered
11.8.5 Serum Institute of India Related Developments
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Corporation Information
11.1.2 Glaxosmithkline Description and Business Overview
11.1.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Glaxosmithkline Cancer Vaccines Products Offered
11.1.5 Glaxosmithkline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cancer Vaccines Market Estimates and Projections by Region
12.1.1 Global Cancer Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Cancer Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Cancer Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Cancer Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Cancer Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Cancer Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Cancer Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Cancer Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cancer Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cancer Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cancer Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cancer Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Cancer Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Cancer Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Cancer Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cancer Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cancer Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cancer Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cancer Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Glaxosmithkline、Astellas Pharma、Merck、CSL Limited、Sanpower Group、Sanofi Pasteur、Pfizer、Serum Institute of India
【免責事項】
https://www.globalresearch.jp/disclaimer